Accolate and Bumex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Accolate (zafirlukast) and Bumex (bumetanide). Common drug interactions include sinusitis among females and blindness among males.

The phase IV clinical study analyzes what interactions people have when they take Accolate and Bumex. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Accolate?

Accolate has active ingredients of zafirlukast. It is often used in asthma. eHealthMe is studying from 4,220 Accolate users. Check the latest studies of Accolate.

What is Bumex?

Bumex has active ingredients of bumetanide. It is often used in swelling. eHealthMe is studying from 9,210 Bumex users. Check the latest studies of Bumex.

On Jul, 11, 2026

25 people who take Accolate and Bumex together, and have interactions are studied.

What are the common drug interactions of Accolate and Bumex, by gender? *:

female:

Sinusitis (inflammation of sinus)
Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Blood pressure decreased
Erythema (redness of the skin)
Eschar (dead tissue that falls off (sheds) from healthy skin)
Generalised oedema (swelling all over the body)
Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
Pollakiuria (abnormally frequent passage of relatively small quantities or urine)

male:

Blindness
Blood glucose increased
Upper respiratory tract infection
Vasculitis (inflammation of a blood vessel or blood vessels)
Cardiac disorder
Churg strauss syndrome (infection of small arteries and vein)
Dyspnoea (difficult or laboured respiration)
Hypoglycaemic seizure (low blood sugar)
Joint dislocation (a joint position is changed from normal position)
Lung function decreased

What are the common drug interactions of Accolate and Bumex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Weakness
Blood pressure decreased
Dyspnoea (difficult or laboured respiration)
Erythema (redness of the skin)
Eschar (dead tissue that falls off (sheds) from healthy skin)
Fatigue (feeling of tiredness)
Generalised oedema (swelling all over the body)
Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
Pruritus (severe itching of the skin)

50-59:

Sinusitis (inflammation of sinus)
Blindness
Blood glucose increased
Calcinosis (calcium deposits in any soft tissue)
Cardiac disorder
Churg strauss syndrome (infection of small arteries and vein)
Cough
Diabetes mellitus inadequate control
Diabetic ulcer
Drug dependence

60+:

Asthenia (weakness)
Confusion
Clostridium difficile sepsis (infection(pus formation) of colon by clostridium difficile bacteria)
Constipation
Cough
Decreased appetite
Dehydration (dryness resulting from the removal of water)
Dizziness
Dry mouth
Dyspnoea (difficult or laboured respiration)

What are the existing conditions these people have? *

Type 2 Diabetes: 6 people, 24.00%
Pain: 6 people, 24.00%
Migraine (headache): 5 people, 20.00%
Stress And Anxiety: 2 people, 8.00%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 8.00%
Irritable Bowel Syndrome: 2 people, 8.00%
Hypersensitivity: 2 people, 8.00%
High Blood Pressure: 2 people, 8.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Accolate and Bumex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously